Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Update: NDA For Androxal Filed

Repros Therapeutics Inc. (NASDAQ:RPRX) yesterday filed the NDA for its late stage candidate Androxal for the treatment of Secondary Hypogonadism. Shares of the company were down 3% following the news of the submission. Repros has 15.70% of its float shorted, and given the history of Androxal the price fall was not too shocking. However, I did expect a price hike following the NDA submission for Androxal, and still expect the price to increase over the days that…